Regulus Therapeutics
RGLS
#8264
Rank
$0.18 B
Marketcap
$2.75
Share price
-1.78%
Change (1 day)
23.87%
Change (1 year)

Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Volume in USD (price x number of shares), data since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$1.09 M-83.41%
2024$6.61 M4258.4%
2023$0.15 M-85.22%
2022$1.02 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
$0.14 B$0.28 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.82 M$53.35 M๐Ÿ‡ซ๐Ÿ‡ท France
$21.47 M$75.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
$38.06 M$0.12 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.85 M$37.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.45 M$6.55 M๐Ÿ‡บ๐Ÿ‡ธ USA
$30 M$0.30 B๐Ÿ‡บ๐Ÿ‡ธ USA